Tasly Xiaoyao tablets were approved by the Dutch Drug Review Board

On September 8, Tasly issued an announcement stating that the company received a notice issued by the Dutch Drug Evaluation Committee regarding the approval of the company’s product Xiaoyao Tablets through drug registration (Traditional UseRegistration), which is used to relieve symptoms such as mental stress and fatigue.

The company submitted the product registration information of Xiaoyao Tablets in December 2019, passed the preliminary review of the Dutch Drug Evaluation Committee in March 2020, passed the EU GMP certification in December 2020, and obtained product registration approval recently

The indications of Xiaoyao Tablets recorded in the Chinese Pharmacopoeia are soothing the liver and invigorating the spleen, nourishing blood and regulating menstruation.

Xiaoyao Tablet is the first compound Chinese medicine variety that has passed the Dutch drug review, and its production line has passed EU GMP certification